SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028098
Filing Date
2018-11-07
Accepted
2018-11-07 16:55:29
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnlo-10q_20180930.htm 10-Q 1620886
2 EX-10.1 mnlo-ex101_191.htm EX-10.1 31591
3 EX-10.2 mnlo-ex102_192.htm EX-10.2 20177
4 EX-31.1 mnlo-ex311_8.htm EX-31.1 16378
5 EX-31.2 mnlo-ex312_6.htm EX-31.2 16391
6 EX-32.1 mnlo-ex321_7.htm EX-32.1 13996
7 GRAPHIC gnrbznb4jhmy000001.jpg GRAPHIC 92410
  Complete submission text file 0001564590-18-028098.txt   5219670

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mnlo-20180930.xml EX-101.INS 1066148
9 XBRL TAXONOMY EXTENSION SCHEMA mnlo-20180930.xsd EX-101.SCH 29499
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnlo-20180930_cal.xml EX-101.CAL 37268
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnlo-20180930_def.xml EX-101.DEF 95732
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnlo-20180930_lab.xml EX-101.LAB 249886
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnlo-20180930_pre.xml EX-101.PRE 183356
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 181167090
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1